These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18841271)

  • 1. Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies--distinguishing "signal" from "noise".
    Warkentin TE
    Thromb Haemost; 2008 Oct; 100(4):523-4. PubMed ID: 18841271
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
    Dellaria SM; Greilich PE; Sarode R
    Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia.
    Whitlatch NL; Perry SL; Ortel TL
    Thromb Haemost; 2008 Oct; 100(4):678-84. PubMed ID: 18841292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies.
    Shoenfeld Y
    Isr J Med Sci; 1997 Apr; 33(4):243-5. PubMed ID: 9347871
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis.
    Cuker A
    Thromb Haemost; 2011 Dec; 106(6):993-4. PubMed ID: 22012630
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia.
    Lee GM; Arepally GM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():668-74. PubMed ID: 24319250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.
    Yeh RW; Everett BM; Foo SY; Dorer DJ; Laposata M; Van Cott EM; Jang IK
    Am J Cardiol; 2006 Aug; 98(3):419-21. PubMed ID: 16860036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-dependent platelet antibodies in children: problem or merely problematic?
    Parker RI
    Pediatr Crit Care Med; 2007 Jul; 8(4):404-5. PubMed ID: 17622926
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin-induced thrombocytopenia: molecular pathogenesis.
    Visentin GP
    Thromb Haemost; 1999 Aug; 82(2):448-56. PubMed ID: 10605736
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

  • 15. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.
    Amiral J; Pouplard C; Vissac AM; Walenga JM; Jeske W; Gruel Y
    Br J Haematol; 2000 May; 109(2):336-41. PubMed ID: 10848821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIT happens: diagnosing and evaluating the patient with heparin-induced thrombocytopenia.
    Greinacher A; Levy JH
    Anesth Analg; 2008 Aug; 107(2):356-8. PubMed ID: 18633006
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.
    Everett BM; Yeh R; Foo SY; Criss D; Van Cott EM; Laposata M; Avery EG; Hoffman WD; Walker J; Torchiana D; Jang IK
    Ann Thorac Surg; 2007 Feb; 83(2):592-7. PubMed ID: 17257993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis.
    Visentin GP; Moghaddam M; Beery SE; McFarland JG; Aster RH
    J Lab Clin Med; 2001 Jul; 138(1):22-31. PubMed ID: 11433225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
    Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
    Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.
    Warkentin TE; Greinacher A; Gruel Y; Aster RH; Chong BH;
    J Thromb Haemost; 2011 Dec; 9(12):2498-500. PubMed ID: 22947414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.